![](https://endpts.com/wp-content/uploads/2021/11/Laurent-Audoly-scaled.jpg)
Laurent Audoly, Parthenon CEO
Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question
Imagine taking an ice pick to the protective barrier that surrounds cancer cells. That’s essentially what Parthenon Therapeutics is trying to do — and now a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.